CMPO September 18th Options Begin Trading

Stock Options Channel highlights two option strategies on Composecure Inc (CMPO, $25.20): selling a $20 put for a $0.25 bid would set an effective purchase basis of $19.75 (21% OTM) with a 69% probability of expiring worthless and a 1.25% return (1.85% annualized) if it does. Conversely, selling a $30 covered call for $0.10 (19% OTM) would generate a 19.44% total return if called at the September 18 expiration, with a 63% chance of expiring worthless and a 0.40% (0.59% annualized) YieldBoost if it does. Implied volatilities are 53% (put) and 60% (call) versus a trailing 12-month volatility of 47%; the site will track odds and contract histories over time.

Analysis

Market structure: The immediate winners are option sellers and market-makers (including NDAQ as exchange beneficiary) because put/call IVs (53%/60%) sit ~13 percentage points above 12‑month realized vol (47%), pricing a volatility risk premium. Small‑cap/likely illiquid CMPO gives sellers pricing power (wider spreads, higher skew) but also amplifies assignment and liquidity risk for buyers; retail flow will dominate supply/demand in the near term. Cross‑asset impact is minimal outside of small‑cap beta — a CMPO gap would exert negligible pressure on bonds/FX/commodities but could shift small‑cap and single‑name option positioning.

Risk assessment: Tail risks are company‑specific shocks (earnings misses, regulatory/FDA-style headlines, or sudden revenue loss) and liquidity shocks that convert small premiums into large mark‑to‑market losses on assignment. Timeframes: expect rapid IV moves in days around catalysts, option decay dominate weeks to Sep 18 expiry, and fundamental risk to play out over quarters. Hidden dependencies include retail gamma (pinning risk), skew asymmetry (call IV>put IV), and broker early assignment; catalysts that could reverse the trade are earnings, sector M&A, or a >20% market drawdown.

Trade implications: For income-biased exposure, selling the Sep 18 CMPO $20 cash‑secured put (collect $0.25) is attractive for small sizing — entry cost basis $19.75 if assigned; size at 0.5–2.0% portfolio (one contract = $2,000 notional). If already long, sell Sep 18 $30 covered call (collect $0.10) to boost return to 19.44% if called; prefer defined‑risk spreads (sell $20/$17 bull‑put or $30/$35 bear‑call) to cap tail risk while harvesting the IV premium. Avoid naked short exposure >2% allocation and require minimum options liquidity (volume/open interest >100) before scaling.

Contrarian angle: The market consensus underestimates execution/liquidity risk — implied vol premium of ~13pp versus realized suggests systematic opportunity to sell vol, but only with defined risk because single‑name shocks are asymmetric. This is likely underdone: small absolute premiums (0.25/0.10) hide outsized P/L if gaps occur; historical parallels (illiquid small caps) show short‑vol profits until a single headline causes >30% moves. Unintended consequence: frequent small income collection can mask cumulative assignment risk and capital tie‑up in a deteriorating equity position.

Key Decisions for Investors

• Sell 1 CMPO Sep 18 $20 cash‑secured put (collect ~$0.25) as a tactical way to target ~21% discount entry (cost basis $19.75 if assigned); size at 0.5–1.0% of portfolio per contract (one contract = $2,000 cash reserved).
• If long CMPO, sell Sep 18 $30 covered call (collect ~$0.10) sized to existing equity (max 3% portfolio exposure) to capture a 0.4% yieldboost (19.44% capped upside); set automatic buy‑back if CMPO > $28 or IV drops >20% intraday to limit assignment risk.
• Prefer defined‑risk spreads over naked selling: execute a Sep 18 bull‑put spread (sell $20 / buy $17) to limit downside to $3 per share while collecting most of the $0.25 premium; keep aggregate vega exposure <2% portfolio and only trade if spot bid/ask spread ≤10% of premium.
• Do not increase naked short put exposure within 10 trading days of any announced company catalyst (earnings/press release); require options liquidity threshold (daily volume or open interest >100 contracts) and monitor IV term structure — add size only if front‑month IV remains ≥10ppt above 3‑month IV.